Outcome of Thromboembolic Events and Its Influence on Survival Time of Advanced NSCLC Patients Treated with Antiangiogenic Therapy

Outcome of Thromboembolic Events and Its Influence on Survival Time of Advanced NSCLC Patients Treated with Antiangiogenic Therapy

Wei-Fan Ou,1 Pei-Ya Liao,1 Yu-Wei Hsu,2,3 Yen-Hsiang Huang,1,4– 6 Kuo-Hsuan Hsu,6,7 Jeng-Sen Tseng,1,4– 6,8 Gee-Chen Chang,4,9– 11 Tsung-Ying Yang1,6,12 1Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan; 2Cancer Prevention and Control...

Full description

Bibliographic Details
Main Authors: Ou WF, Liao PY, Hsu YW, Huang YH, Hsu KH, Tseng JS, Chang GC, Yang TY
Format: Article
Language:English
Published: Dove Medical Press 2023-11-01
Series:Cancer Management and Research
Subjects:
non-small cell lung cancer
nsclc
antiangiogenesis
bevacizumab
ramucirumab
thromboembolism
Online Access:https://www.dovepress.com/outcome-of-thromboembolic-events-and-its-influence-on-survival-time-of-peer-reviewed-fulltext-article-CMAR

Internet

https://www.dovepress.com/outcome-of-thromboembolic-events-and-its-influence-on-survival-time-of-peer-reviewed-fulltext-article-CMAR

Similar Items